461 related articles for article (PubMed ID: 19161911)
1. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
Rosenberg GA
Lancet Neurol; 2009 Feb; 8(2):205-16. PubMed ID: 19161911
[TBL] [Abstract][Full Text] [Related]
2. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.
Mroczko B; Groblewska M; Barcikowska M
J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
[TBL] [Abstract][Full Text] [Related]
4. [Matrix metalloproteinases in the central nervous system: clinical significance and therapeutic prospects].
Sulik A; Ołdak E
Pol Merkur Lekarski; 2008 Mar; 24(141):278-80. PubMed ID: 18634301
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases in neuroinflammation.
Rosenberg GA
Glia; 2002 Sep; 39(3):279-91. PubMed ID: 12203394
[TBL] [Abstract][Full Text] [Related]
6. Multiple roles of metalloproteinases in neurological disorders.
Yang Y; Hill JW; Rosenberg GA
Prog Mol Biol Transl Sci; 2011; 99():241-63. PubMed ID: 21238938
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.
Hu J; Van den Steen PE; Sang QX; Opdenakker G
Nat Rev Drug Discov; 2007 Jun; 6(6):480-98. PubMed ID: 17541420
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.
Rivera S; García-González L; Khrestchatisky M; Baranger K
Cell Mol Life Sci; 2019 Aug; 76(16):3167-3191. PubMed ID: 31197405
[TBL] [Abstract][Full Text] [Related]
9. Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
Brkic M; Balusu S; Libert C; Vandenbroucke RE
Mediators Inflamm; 2015; 2015():620581. PubMed ID: 26538832
[TBL] [Abstract][Full Text] [Related]
10. The role of matrix metalloproteinases in the oral environment.
Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
[TBL] [Abstract][Full Text] [Related]
11. Biological activity and clinical implications of the matrix metalloproteinases.
Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
[TBL] [Abstract][Full Text] [Related]
12. The TIMPs tango with MMPs and more in the central nervous system.
Crocker SJ; Pagenstecher A; Campbell IL
J Neurosci Res; 2004 Jan; 75(1):1-11. PubMed ID: 14689443
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and epidermal wound repair.
Martins VL; Caley M; O'Toole EA
Cell Tissue Res; 2013 Feb; 351(2):255-68. PubMed ID: 22526628
[TBL] [Abstract][Full Text] [Related]
14. Implication of matrix metalloproteinases in regulating neuronal disorder.
Mukherjee A; Swarnakar S
Mol Biol Rep; 2015 Jan; 42(1):1-11. PubMed ID: 25374425
[TBL] [Abstract][Full Text] [Related]
15. TIMPs as multifacial proteins.
Lambert E; Dassé E; Haye B; Petitfrère E
Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders.
Kim YS; Joh TH
Biomol Ther (Seoul); 2012 Mar; 20(2):133-43. PubMed ID: 24116286
[TBL] [Abstract][Full Text] [Related]
17. Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis.
Forget MA; Desrosiers RR; Béliveau R
Can J Physiol Pharmacol; 1999 Jul; 77(7):465-80. PubMed ID: 10535707
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
19. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis.
Muri L; Leppert D; Grandgirard D; Leib SL
Cell Mol Life Sci; 2019 Aug; 76(16):3097-3116. PubMed ID: 31172218
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase inhibition therapy for vascular diseases.
Newby AC
Vascul Pharmacol; 2012; 56(5-6):232-44. PubMed ID: 22326338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
